Evidence map›Paper›PMID 37041727›Full record

ArticleThe American journal of case reports2023

A 25-Year-Old Woman with a High-Risk Large and Occlusive Pulmonary Embolism, Later Diagnosed with Primary Antiphospholipid Syndrome and Hyperhomocysteinemia: A Case Report.

Juan-Manuel Muñoz-Moreno, Anthony Ramos-Yataco, Emanuel Salcedo-Davila, Carlos Alcalde-Loyola, Carina Halanoca-Quispe, Carlos Requena-Armas

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Juan-Manuel Muñoz-MorenoDepartment of Cardiology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.ORCID 0000-0002-2838-1496
Anthony Ramos-YatacoSan Fernando Medical School, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Emanuel Salcedo-DavilaDepartment of Internal Medicine, Olive View-UCLA Medical Center, Los Angeles, CA, USA.
Carlos Alcalde-LoyolaDepartment of Internal Medicine, Hospital Distrital Walter Cruz Vilca, Trujillo, Peru.
Carina Halanoca-QuispeDepartment of Cardiology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.
Carlos Requena-ArmasDepartment of Cardiology, OSF St Francis University of Illinois at Peoria, Peoria, IL, USA.
Hospital Nacional Cayetano Heredia · PENational University of San Marcos · PEOlive View-UCLA Medical Center · USPeoria campus of the University of Illinois System · USPrivate University of Trujillo · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND High-risk pulmonary embolism (PE) occurs when the pulmonary circulation is suddenly occluded by a thrombus and is a life-threatening medical emergency. In young and otherwise healthy individuals, there may be undiagnosed underlying risk factors for PE that require investigation. This report presents the case of a 25-year-old woman admitted as an emergency with a high-risk large and occlusive PE, later diagnosed with primary antiphospholipid syndrome (APS) and hyperhomocysteinemia. CASE REPORT A 25-year-old woman presented with sudden-onset dyspnea after elective cholecystectomy. One year earlier, the patient had lower limb deep vein thrombosis without an identified predisposing cause, and she received anticoagulation for 6 months. On physical examination, she had right leg edema. Laboratory tests revealed elevated levels of troponin, pro-B-type natriuretic peptide, and D-dimer. Computed tomography pulmonary angiography (CTPA) demonstrated a large and occlusive PE, and an echocardiogram showed right ventricular dysfunction. Successful thrombolysis was performed with alteplase. On repeat CTPA, a significant reduction in filling defects in the pulmonary vasculature was observed. The patient evolved uneventfully and was discharged home on a vitamin K antagonist. Due to unprovoked recurrent thrombotic events, suspicion of underlying thrombophilia was raised, and hypercoagulability studies confirmed primary APS and hyperhomocysteinemia. CONCLUSIONS This report presents the case of a life-threatening high-risk PE in a previously healthy young woman and highlights the importance of emergency management followed by investigation and treatment of underlying risk factors for venous thromboembolism, including APS and hyperhomocysteinemia.

Indexed as

Antiphospholipid SyndromeHyperhomocysteinemiaPulmonary EmbolismVenous ThrombosisAdultFemaleHumansTissue Plasminogen ActivatorTissue Plasminogen Activator

Identifiers

PMID37041727
PMCPMC10106094
OpenAlexW4327745076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.